9-127829682-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001114753.3(ENG):c.360+5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001114753.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.360+5G>A | splice_region_variant, intron_variant | Intron 3 of 14 | ENST00000373203.9 | NP_001108225.1 | ||
ENG | NM_000118.4 | c.360+5G>A | splice_region_variant, intron_variant | Intron 3 of 13 | NP_000109.1 | |||
ENG | NM_001278138.2 | c.-187+5G>A | splice_region_variant, intron_variant | Intron 3 of 14 | NP_001265067.1 | |||
ENG | NM_001406715.1 | c.360+5G>A | splice_region_variant, intron_variant | Intron 3 of 7 | NP_001393644.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.360+5G>A | splice_region_variant, intron_variant | Intron 3 of 14 | 1 | NM_001114753.3 | ENSP00000362299.4 | |||
ENG | ENST00000344849.4 | c.360+5G>A | splice_region_variant, intron_variant | Intron 3 of 13 | 1 | ENSP00000341917.3 | ||||
ENG | ENST00000480266.6 | c.-187+5G>A | splice_region_variant, intron_variant | Intron 3 of 14 | 2 | ENSP00000479015.1 | ||||
ENG | ENST00000462196.1 | n.118+5G>A | splice_region_variant, intron_variant | Intron 1 of 3 | 3 | ENSP00000519251.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 1 Pathogenic:2
The ENG c.360+5G>A variant is reported in the literature in an individual with a clinical diagnosis of HHT (Letteboer 2005). In addition, other changes affecting this +5 position (c.360+4_7delAGTG, c.360+5G>C, c.360+5G>T), are also reported in individuals suspected to have HHT (Gedge 2007, Lux 2013). The c.360+5G>A variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This is an intronic variant in a well conserved nucleotide, and computational analyses (Alamut v.2.11) predict that this variant impacts splicing by abolishing the nearby canonical donor splice site. Based on available information, the c.360+5G>A variant is considered to be likely pathogenic. REFERENCES Gedge F et al. Clinical and analytical sensitivities in hereditary hemorrhagic telangiectasia testing and a report of de novo mutations. J Mol Diagn. 2007 Apr;9(2):258-65. Letteboer TG et al. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. Hum Genet. 2005 Jan;116(1-2):8-16. Lux A et al. HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis. Orphanet J Rare Dis. 2013 Jun 27;8:94. -
PM2+PP3+PP4 -
not provided Pathogenic:1
PP3, PM1, PM2, PS4_moderate -
Hereditary hemorrhagic telangiectasia Pathogenic:1
This sequence change falls in intron 3 of the ENG gene. It does not directly change the encoded amino acid sequence of the ENG protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with hereditary hemorrhagic telangiectasia (PMID: 15517393, 32573726; Invitae). ClinVar contains an entry for this variant (Variation ID: 810952). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The c.360+5G>A intronic variant results from a G to A substitution 5 nucleotides after coding exon 3 in the ENG gene. This variant has been reported in an individual with a clinical diagnosis of hereditary hemorrhagic telangiectasia (Letteboer TG et al. Hum. Genet., 2005 Jan;116:8-16). In our clinical cohort, this variant was detected in an individual with epistaxis, telangiectasias, pulmonary ateriovenous malformations, and a family history of hereditary hemorrhagic telangiectasia. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This nucleotide position is highly conserved in available vertebrate species. Using two different splice site prediction tools, this alteration is predicted by BDGP to abolish the native splice donor site, but is predicted to weaken (but not abolish) the efficiency of the native splice donor site by ESEfinder; however, direct evidence is unavailable. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at